Literature DB >> 20842367

Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features.

Giorgio Giaccone1, Michela Morbin, Fabio Moda, Mario Botta, Giulia Mazzoleni, Andrea Uggetti, Marcella Catania, Maria Luisa Moro, Veronica Redaelli, Alberto Spagnoli, Roberta Simona Rossi, Mario Salmona, Giuseppe Di Fede, Fabrizio Tagliavini.   

Abstract

Mutations of three different genes, encoding β-amyloid precursor protein (APP), presenilin 1 and presenilin 2 are associated with familial Alzheimer's disease (AD). Recently, the APP mutation A673V has been identified that stands out from all the genetic defects previously reported in these three genes, since it causes the disease only in the homozygous state (Di Fede et al. in Science 323:1473-1477, 2009). We here provide the detailed neuropathological picture of the proband of this family, who was homozygous for the APP A673V mutation and recently came to death. The brain has been studied by histological and immunohistochemical techniques, at the optical and ultrastructural levels. Cerebral Aβ accumulation and tau pathology were severe and extensive. Peculiar features were the configuration of the Aβ deposits that were of large size, mostly perivascular and exhibited a close correspondence between the pattern elicited by amyloid stainings and the labeling obtained with immunoreagents specific for Aβ40 or Aβ42. Moreover, Aβ deposition spared the neostriatum while deeply affecting the cerebellum, and therefore was not in compliance with the hierarchical topographical sequence of involvement documented in sporadic AD. Therefore, the neuropathological picture of familial AD caused by the APP recessive mutation A673V presents distinctive characteristics compared to sporadic AD or familial AD inherited as a dominant trait. Main peculiar features are the morphology, structural properties and composition of the Aβ deposits as well as their topographic distribution in the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842367     DOI: 10.1007/s00401-010-0747-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients.

Authors:  Ebba Lohmann; Rita J Guerreiro; Nihan Erginel-Unaltuna; Nicole Gurunlian; Basar Bilgic; Hakan Gurvit; Hasmet A Hanagasi; Nga Luu; Murat Emre; Andrew Singleton
Journal:  Neurobiol Aging       Date:  2012-04-13       Impact factor: 4.673

2.  Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragment.

Authors:  Gisela Esquerda-Canals; Joaquim Marti; Geovanny Rivera-Hernández; Lydia Giménez-Llort; Sandra Villegas
Journal:  MAbs       Date:  2013-06-20       Impact factor: 5.857

3.  Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide.

Authors:  Asa Hatami; Sanaz Monjazeb; Saskia Milton; Charles G Glabe
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

4.  A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.

Authors:  Thorlakur Jonsson; Jasvinder K Atwal; Stacy Steinberg; Jon Snaedal; Palmi V Jonsson; Sigurbjorn Bjornsson; Hreinn Stefansson; Patrick Sulem; Daniel Gudbjartsson; Janice Maloney; Kwame Hoyte; Amy Gustafson; Yichin Liu; Yanmei Lu; Tushar Bhangale; Robert R Graham; Johanna Huttenlocher; Gyda Bjornsdottir; Ole A Andreassen; Erik G Jönsson; Aarno Palotie; Timothy W Behrens; Olafur T Magnusson; Augustine Kong; Unnur Thorsteinsdottir; Ryan J Watts; Kari Stefansson
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

5.  The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.

Authors:  Iryna Benilova; Rodrigo Gallardo; Andreea-Alexandra Ungureanu; Virginia Castillo Cano; An Snellinx; Meine Ramakers; Carmen Bartic; Frederic Rousseau; Joost Schymkowitz; Bart De Strooper
Journal:  J Biol Chem       Date:  2014-09-24       Impact factor: 5.157

6.  The peculiar role of the A2V mutation in amyloid-β (Aβ) 1-42 molecular assembly.

Authors:  Massimo Messa; Laura Colombo; Elena del Favero; Laura Cantù; Tatiana Stoilova; Alfredo Cagnotto; Alessandro Rossi; Michela Morbin; Giuseppe Di Fede; Fabrizio Tagliavini; Mario Salmona
Journal:  J Biol Chem       Date:  2014-07-18       Impact factor: 5.157

Review 7.  Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.

Authors:  Hongyi Li; Yang Yang; Weiqi Hong; Mengyuan Huang; Min Wu; Xia Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-01-03

Review 8.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

9.  β-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects.

Authors:  Brian Hitt; Sean M Riordan; Lokesh Kukreja; William A Eimer; Tharinda W Rajapaksha; Robert Vassar
Journal:  J Biol Chem       Date:  2012-09-17       Impact factor: 5.157

10.  Specific recognition of biologically active amyloid-β oligomers by a new surface plasmon resonance-based immunoassay and an in vivo assay in Caenorhabditis elegans.

Authors:  Matteo Stravalaci; Antonio Bastone; Marten Beeg; Alfredo Cagnotto; Laura Colombo; Giuseppe Di Fede; Fabrizio Tagliavini; Laura Cantù; Elena Del Favero; Michele Mazzanti; Roberto Chiesa; Mario Salmona; Luisa Diomede; Marco Gobbi
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.